C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2006
10/17/2006	US7122321 Evaluating activity of proteins; obtain protein, incubate with modulators, generate activity spectrum, classify protein
10/17/2006	US7122317 Identifying transcription factors for use in modulation of gene expression; high-throughput assay
10/17/2006	US7122316 Combining mixture of RNA polymerase and reversible inhibitor of RNA polymerase (reversible inhibitor does not hybridize to a target nucleic acid sequence), with sample suspected to contain target nucleic acid, exposing to amplification
10/17/2006	US7122313 Methods and kits for identifying and quantifying RNAs and DNAs associated with RNA and DNA binding proteins
10/17/2006	US7122312 Methods for drug target screening
10/17/2006	US7122311 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders
10/17/2006	US7122310 Generation of self-assembling sequences; obtain oligonucleotide sequences, denature, incubate with probes, allow hybridization, recover products
10/17/2006	US7122309 High throughput screening assay for detecting a DNA sequence
10/17/2006	US7122305 Methods and compositions for identifying receptor effectors
10/17/2006	US7122304 Methods for the storage and synthesis of nucleic acids using a solid support
10/17/2006	US7122302 Method for determining early HCV seroconversion
10/17/2006	US7122197 Compounds from Moraxella catarrhalis
10/17/2006	US7122196 Compounds and methods for diagnosis of tuberculosis
10/17/2006	US7122190 Peptide containing amino acids 638 to 673 of the HIV-1LAI gp41 protein, and fragments, analogs and homologs of DP178, inhibitory of human and nonhuman retroviral, especially HIV, transmission to uninfected cells
10/17/2006	US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody
10/17/2006	US7122185 Nucleic acids; prevent humans lymphocyte virus infection; genetic engineering; transformation cells
10/17/2006	US7122184 Monoclonal antibody for use in prevention of fungal infections
10/17/2006	US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L
10/17/2006	US7122181 Gene therapy; eye diseases
10/17/2006	US7122180 DNA vectors containing mutated HIV proviruses
10/17/2006	CA2359659C Method for quality control of an attenuated varicella live vaccine
10/17/2006	CA2293808C Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
10/17/2006	CA2195557C Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
10/17/2006	CA2177179C Antagonists to chaperonin 10
10/17/2006	CA2150497C Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase
10/12/2006	WO2006108123A1 Directed complementation
10/12/2006	WO2006107931A2 Polynucleotides and methods for making plants resistant to fungal pathogens
10/12/2006	WO2006107826A2 Micro-rna's that regulate muscle cells
10/12/2006	WO2006107761A2 Axmi-027, axmi-036 and axmi-038, a family of delta-endotoxin genes and methods for their use
10/12/2006	WO2006107084A1 Yeast mutant strain capable of producing secreted thermostable enzyme in high secretion level
10/12/2006	WO2006107031A1 Method of relative risk for the onset of atopic dermatitis by gene single nucleotide polymorphism analysis
10/12/2006	WO2006106970A1 Process for production of protein having triple-helical structure
10/12/2006	WO2006106959A1 Anti-cd-20 monoclonal antibody
10/12/2006	WO2006106957A1 Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same
10/12/2006	WO2006106950A1 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate
10/12/2006	WO2006106930A1 NUCLEIC ACID PROBE CONTAINING Eu3+ COMPLEX AND METHOD OF ANALYZING NUCLEIC ACID BY USING THE SAME
10/12/2006	WO2006106912A1 Cancer-associated antigen analog peptide and utilization of the same
10/12/2006	WO2006106905A1 Process for production of polypeptide by regulation of assembly
10/12/2006	WO2006106903A1 sc(Fv)2 STRUCTURAL ISOMERS
10/12/2006	WO2006106882A1 Method of measuring luminescence dose at definite site, apparatus for measuring luminescence dose at definite site, method of measuring expression amount and measurement apparatus therefor
10/12/2006	WO2006106867A1 Apparatus for determining gene polymorphism
10/12/2006	WO2006106848A1 Method for bonding substrates, method for forming chip, and chip
10/12/2006	WO2006106839A1 METHOD FOR SCREENING AUXILIARY AGENT CAPABLE OF PROMOTING THE INDUCTION OF INTERFERON-α AND/OR -β (IFN-α/β) EXPRESSION
10/12/2006	WO2006106823A1 Method for distinguishing mesenchymal stem cell using molecular marker and use thereof
10/12/2006	WO2006106741A1 Bioreaction execution apparatus, method of bioreaction execution, dna chip, information processing unit, method of information processing, program and recording medium
10/12/2006	WO2006106678A1 Boron absorption-promoting gene
10/12/2006	WO2006106661A1 Method for display of determination information of biologically relevant substance
10/12/2006	WO2006106336A2 Rat primers
10/12/2006	WO2006106331A2 Mouse primers
10/12/2006	WO2006106193A1 Method for obtaining soluble or better expressed variants of a protein of interest
10/12/2006	WO2006105972A1 Transgenic organism expressing cd40l and uses thereof
10/12/2006	WO2006105946A2 Methods and means for removal of a selected dna sequence
10/12/2006	WO2006105801A1 Genetically engineered biosensor to monitor toxicity of chemical pollutants in liquids
10/12/2006	WO2006105602A1 Animal models and cells with a modified gene encoding transthyretin-related protein and applications thereof
10/12/2006	WO2006105598A1 Plant genetic sequences associated with vacuolar ph and uses thereof
10/12/2006	WO2006105597A1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
10/12/2006	WO2006087637A3 Anti her2/neu antibody
10/12/2006	WO2006078431A3 Compositions and methods related to modified retroviral vectors for restricted, site specific integration
10/12/2006	WO2006065137A3 Novel efficient production process for capsular polysaccharides of pathogenic grampositive bacteria by heterologous expression and secretion of complex polysaccharides in non-pathogenic, non-invasive gram- positive bacteria
10/12/2006	WO2006053743A3 Arabidopsis and brassica nucleic acid sequences conferring lipid and sugar alterations in plants and methods of use
10/12/2006	WO2006047680A3 Lactobacillus acidophilus nucleic acids and uses thereof
10/12/2006	WO2006039792A8 Method of treating autoimmune diseases
10/12/2006	WO2006020717A3 Nucleic acids conferring lipid and sugar alterations in plants ii
10/12/2006	WO2006012024A3 Cell number polynucleotides and polypeptides and methods of use thereof
10/12/2006	WO2006010096A3 Genetic manipulation of condensed tannins
10/12/2006	WO2006002202A3 Nerve regeneration
10/12/2006	WO2005123774A3 Antibodies to west nile virus polypeptides
10/12/2006	WO2005099440A3 Methods for recovering products from plants
10/12/2006	WO2005092030A3 Methods of use of bcl-6-derived nucleotides to induce apoptosis
10/12/2006	WO2005086695A3 Intracellular interleukin-1 receptor antagonist and uses thereof
10/12/2006	WO2005072290A3 Methods of treating, reducing, or preventing autoimmune conditions
10/12/2006	WO2004112703A3 Interleukin-21 analogs
10/12/2006	WO2003073821A3 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER
10/12/2006	US20060230473 DNA sequences of the recombinant constructs inserted into the corn genome that resulted in the 3272 event; detecting the presence of DNA corresponding to the corn event 3272
10/12/2006	US20060230471 Expression vector comprising nucleotide sequences coding polypeptides for generation and propagation of drought, freeze and salt resistant plants
10/12/2006	US20060230470 Promoter expressing foreign gene in root and shoot apex
10/12/2006	US20060230469 Method and means for determining fitness in plants
10/12/2006	US20060230468 Novel Pcr family genes which confer tolerance to heavy metals
10/12/2006	US20060230467 Plant deoxyribonucleoside kinase enzymes and their use
10/12/2006	US20060230466 Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof
10/12/2006	US20060229470 Calcium receptor-active molecules
10/12/2006	US20060229434 Low-molecular weight peptides inhibiting ion channel activity
10/12/2006	US20060229273 High affinity oligonucleotide ligands to growth factors
10/12/2006	US20060229271 Methods for treating infectious disease exacerbated asthma
10/12/2006	US20060229270 Methods of treating proteinuria by reducing double-stranded DNA antibodies
10/12/2006	US20060229269 administering to a subject having cerebral vasospasm an effective amount for treating cerebral vasospasm of a R-type voltage-dependent calcium channel inhibitor SNX-482 ( a polypeptide from spider; toxin from the venom of the tarantula Hysterocrates gigas)
10/12/2006	US20060229268 Small interference RNA (siRNA) molecules for modulating superoxide dismutase (SOD)
10/12/2006	US20060229267 Two nucleotides containing 5-methylcytosine, the first hybridizing to the promoter region of a c-Ha-ras gene and the second hybridizing to a different type of oncogene; anticarcinogenic agents for melanomas, pancreatic, colon, breast, bladder, lung, leukemia, prostate, lymphoma, and ovarian cancers
10/12/2006	US20060229266 Silencing of tgf-beta receptor type II expression by sirna
10/12/2006	US20060229246 Peptide-enhanced transfections
10/12/2006	US20060229234 Peptide factor
10/12/2006	US20060229223 Having specific base substitutions and improved thermostability; controlling pitch troubles in pulping or papermaking; detergents; removing hydrophobic esters from fabrics; catalyst for hydrolysis or synthesis of esters
10/12/2006	US20060228800 Novel Transgenic Methods Using intronic RNA
10/12/2006	US20060228799 Use of consensus sequences for targeted homologous gene isolation and recombination in gene families
10/12/2006	US20060228798 Homologous recombination in multipotent adult progenitor cells
10/12/2006	US20060228797 Method for altering the metabolism of plant
10/12/2006	US20060228791 Subtilases and subtilase variants having altered immunogenicity
10/12/2006	US20060228790 L-glutamate oxidase
10/12/2006	US20060228783 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides
10/12/2006	US20060228782 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders

1 ... 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 ... 4023